Cost-effectiveness of treating multidrug-resistant tuberculosis.
Despite the existence of effective drug treatments, tuberculosis (TB) causes 2 million deaths annually worldwide. Effective treatment is complicated by multidrug-resistant TB (MDR TB) strains that respond only to second-line drugs. We projected the health benefits and cost-effectiveness of using dru...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2006-07-01
|
| Series: | PLoS Medicine |
| Online Access: | http://europepmc.org/articles/PMC1483913?pdf=render |